Clinical Trials Directory

Trials / Unknown

UnknownNCT04912349

Comparison of TUSP Versus TURP for Treatment of Benign Prostatic Hyperplasia in a Small Prostate Volume

Comparison of Transurethral Split of the Prostate Versus Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia in a Small Prostate Volume: A Prospective Controlled Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
Male
Age
35 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Comparison of transurethral split of the prostate versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia in a small prostate volume: A prospective controlled study

Detailed description

Transurethral resection of the prostate (TURP) was considered as the golden standard to treat benign prostatic hyperplasia (BPH) for decades. However, TURP was associated with low efficiency to alleviate the lower urinary tract symptoms and a significantly higher risk of bladder neck contracture (BNC) for patients with small-volume BPH. We aimed to compare the therapeutic effect of transurethral split of the prostate (TUSP) with TURP for patients with small-volume BPH (\<30 ml). In this study, some selected small-volume BPH patients were randomly divided into two groups (TUSP and TURP group). The patient's baseline characteristics and perioperative outcomes were recorded. The follow-up was made at 6 months, 1 year and 2 years after surgical treatment.

Conditions

Interventions

TypeNameDescription
PROCEDURETUSPPatients received the transurethral split of the prostate(TUSP) treatment.
PROCEDURETURPPatients received the transurethral resection of the prostate(TURP) treatment.

Timeline

Start date
2020-07-01
Primary completion
2022-06-30
Completion
2022-06-30
First posted
2021-06-03
Last updated
2021-06-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04912349. Inclusion in this directory is not an endorsement.